MENU
CytomX Therapeutics (CTMX) Ownership - Who owns CytomX Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
151 Oyster Point Boulevard
Phone
+1 650 515-3185
Employees
122
Web
https://www.cytomx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
93.74M
P/E Ratio
8.00
Total Cash
137.18M
Projected Growth
N/A
Total Debt
11.75M
Revenue
119.57M
Risk (Beta)
1.27
Dividend Yield
N/A
Total Cash/Share
1.76
Total Debt/Equity
N/A
Revenue/Share
1.45 USD as % of share price
Fundamentals
CTMX
Capitalization
93.7M
P/E Ratio
8.00
Risk (Beta)
1.27
Dividend Yield
N/A
Total Cash
137M
Total Cash/Share
1.76
Total Debt
11.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.45%
Revenue
120M
ROE
N/A
Book Value
-31.23M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
1.00
Current Revenue Per Employee
205860.66
Dividends Per Share - Security
N/A
EBITDA
7.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
6.02
Shares Held By Institutions
86.1M
Shares Outstanding - Current
78.1M
Total Liabilities
190M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-23.226
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
151 Oyster Point Boulevard
Phone
+1 650 515-3185
Employees
122
Web
https://www.cytomx.com